Advertisement

  • What Is Tumor Mutational Burden?

    The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types.

    by Anna Azvolinsky

  • Survivor Profile

    An Unlikely Pivot

    Medha Deoras-Sutliff’s experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers.

    by Lindsey Konkel

  • Survivor Profile

    Sharing Her Strength

    Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

    by Lindsey Konkel

  • Advocacy in Action

    Leaving a Legacy

    Two mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.

    by Esther Landhuis

  • A Unified Strategy

    A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.

    by Marci A. Landsmann

  • Finding More Targets for CAR-T Cells

    CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.

    by Kendall K. Morgan

  • Survivor Profile

    Still in the Game

    ESPN reporter Holly Rowe worked through melanoma treatment.

    by Lindsey Konkel

  • More Options for Rare Cancers

    Precision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.

    by Kendall K. Morgan

  • An Uncommon Partnership

    Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.

    by Ashley P. Taylor

  • Learning to Share

    At first, I wanted to hide my cancer diagnosis. My son showed me what a mistake that was.

    by Lenn Robbins

Advertisement
Advertisement

From the AACR

  • Cervical Cancer Awareness

    The incidence of cervical cancer has been decreasing in the U.S. in recent decades, aided by the implementation of human papillomavirus vaccines.

  • Breast Cancer and COVID-19

    Patients with cancer have a higher risk of mortality from COVID-19, and the pandemic is disproportionately affecting racial and ethnic minorities.

  • Harnessing Genomic Data

    As AACR Project GENIE marked its fifth anniversary, more than 7,900 individuals are registered to use the public data, and 296 papers have cited the registry.

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR